Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption
In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, a...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-12-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.607849/full |
| _version_ | 1819171599208677376 |
|---|---|
| author | Yinke Du Zhipeng Qi Jiangwei Ma Da Sun Li Yao Bin Xu Wei Liu Zhaofa Xu Yu Deng |
| author_facet | Yinke Du Zhipeng Qi Jiangwei Ma Da Sun Li Yao Bin Xu Wei Liu Zhaofa Xu Yu Deng |
| author_sort | Yinke Du |
| collection | DOAJ |
| description | In December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, and tumor necrosis factor-α, were found in patients with COVID-19, which implies the occurrence of a cytokine storm and its association with disease severity. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. In this study, we report on a patient with COVID-19 who benefited from hemoadsorption. |
| first_indexed | 2024-12-22T19:53:51Z |
| format | Article |
| id | doaj.art-f4074f125d194ef5ab5808d33904f2d0 |
| institution | Directory Open Access Journal |
| issn | 2296-858X |
| language | English |
| last_indexed | 2024-12-22T19:53:51Z |
| publishDate | 2020-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Medicine |
| spelling | doaj.art-f4074f125d194ef5ab5808d33904f2d02022-12-21T18:14:29ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-12-01710.3389/fmed.2020.607849607849Case Report: A Patient With COVID-19 Who Benefited From HemoadsorptionYinke Du0Zhipeng Qi1Jiangwei Ma2Da Sun3Li Yao4Bin Xu5Wei Liu6Zhaofa Xu7Yu Deng8Department of Nephrology, First Hospital of China Medical University, Shenyang, ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang, ChinaDepartment of Pulmonary and Critical Care Medicine, First Hospital of China Medical University, Shenyang, ChinaDepartment of Nephrology, First Hospital of China Medical University, Shenyang, ChinaDepartment of Nephrology, First Hospital of China Medical University, Shenyang, ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang, ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang, ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang, ChinaDepartment of Environmental Health, School of Public Health, China Medical University, Shenyang, ChinaIn December 2019, the 2019 novel coronavirus disease (COVID-19), which has been identified to be caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China and spread across the world. Higher plasma levels of cytokines, including interleukin (IL)-6, IL-2, IL-7, IL-10, and tumor necrosis factor-α, were found in patients with COVID-19, which implies the occurrence of a cytokine storm and its association with disease severity. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. In this study, we report on a patient with COVID-19 who benefited from hemoadsorption.https://www.frontiersin.org/articles/10.3389/fmed.2020.607849/full2019-nCoVCOVID-19epidemicextracorporeal blood purificationtreatment |
| spellingShingle | Yinke Du Zhipeng Qi Jiangwei Ma Da Sun Li Yao Bin Xu Wei Liu Zhaofa Xu Yu Deng Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption Frontiers in Medicine 2019-nCoV COVID-19 epidemic extracorporeal blood purification treatment |
| title | Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption |
| title_full | Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption |
| title_fullStr | Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption |
| title_full_unstemmed | Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption |
| title_short | Case Report: A Patient With COVID-19 Who Benefited From Hemoadsorption |
| title_sort | case report a patient with covid 19 who benefited from hemoadsorption |
| topic | 2019-nCoV COVID-19 epidemic extracorporeal blood purification treatment |
| url | https://www.frontiersin.org/articles/10.3389/fmed.2020.607849/full |
| work_keys_str_mv | AT yinkedu casereportapatientwithcovid19whobenefitedfromhemoadsorption AT zhipengqi casereportapatientwithcovid19whobenefitedfromhemoadsorption AT jiangweima casereportapatientwithcovid19whobenefitedfromhemoadsorption AT dasun casereportapatientwithcovid19whobenefitedfromhemoadsorption AT liyao casereportapatientwithcovid19whobenefitedfromhemoadsorption AT binxu casereportapatientwithcovid19whobenefitedfromhemoadsorption AT weiliu casereportapatientwithcovid19whobenefitedfromhemoadsorption AT zhaofaxu casereportapatientwithcovid19whobenefitedfromhemoadsorption AT yudeng casereportapatientwithcovid19whobenefitedfromhemoadsorption |